-
55,000 people study: drinking cancer, but inevitably drink how to do? Doing so reduces the risk.
Time of Update: 2020-07-17
source: the International Journal of cancer analyzed data from the England health survey (HSE) and the Scottish Health Survey (SHS), involving 54686 subjects with an average age of 51 years, to assess the relationship between exercise, alcohol consumption, and the risk of cancer death.
-
The treatment practice of CIP was shared after treatment of Navuliu monoto-hypertherapy in a case of lung adenocarcinoma.
Time of Update: 2020-07-17
Lung cancer is the first cancer in China. patients with lung adenocarcinoma have poor overall prognosis due to their strong tumor invasion, high metastasis rate, rapid disease progression and low effi
-
The meeting concluded with the 2020 EHA Meeting Express - Lymphoma and Myeloma Special Session.
Time of Update: 2020-07-17
On the morning of July 4, 2020, the "post EHA express lymphoma & amp; myeloma special session" jointly organized by the myeloma and lymphoma MSL team of Xi'an YANGSEN medical department was successful
-
Professor Sheng Xinan: Highlights of the 2020 CSCO Kidney Cancer Treatment Guidelines.
Time of Update: 2020-07-17
internal medicine part - second line treatment compared with the 2019 version of the guidelines, this year's guidelines add the combination of rivarotinib and pabolizumab, which can be used as a level III recommendation for the follow-up treatment of advanced renal cell carcinoma.
-
Application of deep learning in CT images: The use of convolutional neural networks to automatically detect lung nodules for subsequent management.
Time of Update: 2020-07-17
The contents were summarized as follows: Objective: To compare the computer-aided detection based on 3D convolutional neural network (CNN) Detection (CAD) model and different levels of experience of radiologists in the detection of pulmonary nodules on thin slice CT.
-
Express . . . Keytruda is qualified by the FDA for priority review, single-drug treatment for recurrent/refractive classic Hodgkin's lymphoma.
Time of Update: 2020-07-17
▎ recently, MSD announced that the US Food and Drug Administration (FDA) has accepted its application for the license of supplementary biological products (SBLA) for the heavyweight PD-1 inhibitor keytruda, and has granted it priority for review as a monotherapy for adult patients with relapsed / refractory classical Hodgkin's lymphoma (CHL).
-
"China colorectal cancer early diagnosis and treatment expert consensus" released! Guide consensus.
Time of Update: 2020-07-17
if the compliance of screening objects is poor, multi-target fecal DNA test can be carried out for patients with positive screening or those who refuse to be screened, and colonoscopy is recommended for those who are positive.
-
A paper counts the treatment of N-lazy B cells for non-Hodgkin's lymphoma.
Time of Update: 2020-07-17
Author: Du Du Ma, this article is authorized by the author to release yimaitong. Please do not reprint without authorization. lymphoma can be divided into Hodgkin's lymphoma (HL) and non Hodgkin's lym
-
Express . . . GlaxoSmithKline's BCMA antibody coupling drug is expected to be approved after a 12-0 vote by the advisory board.
Time of Update: 2020-07-17
GlaxoSmithKline (GSK), editor of the content team of Wuxi apptec, announced today that the US Food and Drug Administration (FDA) oncology drug advisory committee (ODAC) voted 12-0 to support the company's development of an antibody conjugated drug targeting B-cell mature antigen (BCMA) In the treatment of relapsed / refractory multiple myeloma patients, the benefits outweigh the risks.
-
The two ends meet together, wonderful: head and neck tumor big curry a total of 2020 CSCO head and neck tumor guide release!
Time of Update: 2020-07-17
The 2020 CSCO guidelines for head and neck cancer and Summit Forum on precision / immunotherapy of head and neck cancer were held in Shanghai on July 12, 2020. this meeting is sponsored by the Orienta
-
Can you cut the tumor gene in a beam of light? East China Normal University has developed a new optical control gene editing system.
Time of Update: 2020-07-17
in 2017, the research group published a cover research article in the journal Science Translational Medicine, using far red light to control gene expression, realizing the goal of ultra remote control of insulin release from photosensitive cells by smart phones to treat diabetes, and subverted the traditional method of oral and injection hypoglycemic drugs to control blood glucose.
-
Local therapy or systemic therapy? Which type of recurrent breast cancer is preferred for surgery?
Time of Update: 2020-07-17
in Figure 1, the pros and cons of the debate are as follows: Professor Zhu Li (left); Professor Song Chuangui (right) interjects: local treatment is the first choice for operable recurrent breast cancer.
-
New study from Indiana University: CtDNA and CTC combined to predict breast cancer recurrence more accurately.
Time of Update: 2020-07-17
according to a new study, a combined method of measuring circulating tumor DNA (cfdna) and circulating tumor cells (CTC) can detect residual disease after neoadjuvant chemotherapy in patients with triple negative breast cancer (TNBC) and predict the recurrence of breast cancer.
-
New pretreatment of blood tumor targeted therapy? New Sharp Bio has received $110 million to push hematopoietic stem cells into clinical medicine.
Time of Update: 2020-07-17
VOR said that its core technology, engineered hematopoietic stem cells (ehsc), has a strong potential to expand the scope of application of targeted therapy for blood tumors and avoid therapeutic adverse events caused by the killing of therapeutic molecules on healthy cells.
-
Public data sent 5 plus, the province of the flower.
Time of Update: 2020-07-17
Mutation comparison among three methylation clusters in cervical cancer Fig. 5 amplification and deletion of methylation h, m and l methylation genes; construction of prognostic model for 3.5 HPV related methylation markers; univariate Cox regression analysis identified 20 methylation sites with prognostic significance.
-
What's the harm of long-term day-night reversals? These 8 pictures tell you.
Time of Update: 2020-07-17
Figure 1 nature Chronic circadian rhythm disorder can regulate the characteristics of tumor stem cells and immune microenvironment, thus causing breast cancer metastasis in mice.
-
"Optimized Edition" Herceptin! FC optimized immune-enhanced antibody margetuximab treatment of stomach cancer is strong, and then Ding medicine was introduced into China for development!
Time of Update: 2020-07-17
!--webeditor: "page title" - - July 11, 2020 /PRNewswire/ -- Reding Pharmaceutical Partners MacroGenics recently announced the evaluation of HER2 target antibody margetuximab in conjunction with Merca
-
Anti-Trop-2 ADC drug Trodelvy combined with PD-L1 monoantitic Tecentriq: Treatment of urethral derilopathy and non-small cell lung cancer.
Time of Update: 2020-07-17
The !---- leading biopharmaceutical company in the field of antibody drug coupling (ADC) has announced a partnership with Roche to assess the potential of Thetreves, Immunomedic's anti-Trop-2 ADC drug
-
The Guide to the Diagnosis and Treatment of Multiple Myeloma in China (Revised 2020) interprets the summary of public welfare project activities online.
Time of Update: 2020-07-17
"Guidelines for diagnosis and treatment of multiple myeloma in China (revised in 2020)" jointly sponsored by hematologists branch of Chinese Medical Doctor Association, multiple myeloma Professional Committee of Chinese Medical Doctor Association and China primary health care foundation ”The public welfare project, four sessions of online interpretation meeting, have been successfully concluded.
-
Summary: Risk factors for hepatocellular carcinoma.
Time of Update: 2020-07-17
is noteworthy that the incidence rate of HCC depends not only on race / ethnicity, gender, age, geographic / demographic factors, but also on several risk factors, such as cirrhosis, hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, excessive drinking, non-alcoholic fatty liver disease (NAFLD), obesity, diabetes, metabolic syndrome and environmental toxicity.
